Boothbay Fund Management, LLC Intercept Pharmaceuticals, Inc. Put Options Transaction History

Boothbay Fund Management, LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2023 Nov 14, 2023	BUY	$9.99 - $18.71 $20,979 - $39,291	2,100 Added 0.25%	848,800 $15.7 Million
Q2 2023 Aug 14, 2023	BUY	$9.17 - $19.29 $7.76 Million - $16.3 Million	846,700 New	846,700 $9.36 Million
Q1 2022 May 16, 2022	SELL	$13.37 - $17.79 $2.45 Million - $3.27 Million	-183,600 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$14.28 - $19.53 $1.96 Million - $2.68 Million	137,300 Added 296.54%	183,600 $2.99 Million
Q3 2021 Nov 15, 2021	BUY	$12.99 - $20.47 $601,437 - $947,761	46,300 New	46,300 $688,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.